You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / CE

Assess Your Diagnosis and Management of Bipolar Disorder

  • Authors: Trisha Suppes, MD, PhD
  • CME / CE Released: 8/31/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/31/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for psychiatrists, primary care physicians, and neurologists.

The goal of this activity is to improve awareness and knowledge related to the diagnosis and management of bipolar disorder and bipolar depression.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Diagnostic criteria for bipolar I and II
  • Self-assess learning needs related to
    • Managing bipolar depression


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Trisha Suppes, MD, PhD

    Professor, Psychiatry and Behavioral Sciences
    Stanford University School of Medicine
    Stanford, California
    Director, Palo Alto CSP NODES Program
    VA Palo Alto Health Care System
    Palo Alto, California

    Disclosures

    Disclosure: Trisha Suppes, MD, PhD, has the following relevant financial relationships: 
    Advisor or consultant for: Impel NeuroPharma, Inc.; Intra-Cellular Therapies, Inc.; Sunovion Pharmaceuticals Inc.
    Speaker or a member of a speakers bureau for: SERVIER (Australia); Sunovion Pharmaceuticals Inc. 
    Grants for clinical research from: Merck & Co., Inc.

Steering Committee

  • Christoph Correll, MD

    Professor of Psychiatry and Molecular Medicine 
    Zucker School of Medicine at Hofstra/Northwell, New York 
    Medical Director 
    Recognition and Prevention Program 
    Zucker Hillside Hospital 
    Glen Oaks, New York

    Disclosures

    Disclosure: Christoph Correll, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: AbbVie Inc.; Acadia Pharmaceuticals Inc.; Alkermes, Inc.; Allergan, Inc.; Angelini; Aristo; Axsome; Damitsa; Gedeon Richter; Hikma; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Karuna; LB Pharma; Lundbeck, Inc.; MedAvante-ProPhase; MedInCell; Merck; Mitsubishi Tanabe Pharma Corporation; Mylan Laboratories Inc.; Neurocrine; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Recordati S.p.A.; ROVI; SERVIER; Sumitomo Dainippon; Sunovion Pharmaceuticals Inc.; Supernus; Takeda Pharmaceuticals North America, Inc.; Teva Pharmaceuticals, USA; Viatris 
    Served as a speaker or a member of a speakers bureau for: Angelini; Aristo; Damitsa; Gedeon Richter; Hikma; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Lundbeck, Inc.; Mitsubishi Tanabe Pharma Corporation; Mylan Laboratories Inc.; Otsuka Pharmaceutical Co., Ltd.; Recordati S.p.A.; Sumitomo Dainippon; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals North America, Inc.; Viatris 
    Received grants for clinical research from: Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc. 
    Owns stock, stock options, or bonds from: LB Pharma 
    Royalties or patent beneficiary: UpToDate

  • E. Sherwood Brown, MD, PhD, MBA

    Professor of Psychiatry 
    Aradine S. Ard Chair in Brain Science 
    Lou and Ellen McGinley Distinguished Chair in Psychiatric Research 
    Vice Chair for Clinical Research 
    Director of the Psychoneuroendocrine Research Program 
    UT Southwestern Medical Center 
    Dallas, Texas 

    Disclosures

    Disclosure: E. Sherwood Brown, MD, PhD, MBA, has disclosed no relevant financial relationships. 

  • Leslie Citrome, MD, MPH

    Clinical Professor 
    Psychiatry and Behavioral Sciences 
    New York Medical College 
    Valhalla, New York

    Disclosures

    Disclosure: Leslie Citrome, MD, MPH, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: AbbVie Inc.; Acadia Pharmaceuticals Inc.; Adamas; Alkermes, Inc.; Allergan, Inc.; Angelini; Astellas Pharma, Inc.; Avanir Pharmaceuticals; Axsome; BioXcel; Boehringer Ingelheim Pharmaceuticals, Inc.; Cadent Therapeutics; Eisai Inc.; Impel NeuroPharma, Inc.; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals, Inc.; Karuna; Lundbeck, Inc.; Lyndra; MedAvante-ProPhase; Merck; Neurocrine; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Ovid; Relmada; Reviva; Sage; Sunovion Pharmaceuticals Inc.; Teva Pharmaceuticals, USA
    Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Acadia Pharmaceuticals Inc.; Alkermes, Inc.; Allergan, Inc.; Angelini; Eisai; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals, Inc.; Lundbeck, Inc.; Neurocrine; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals North America, Inc.; Teva Pharmaceuticals, USA; Vindico 
    Owns stock, stock options, or bonds from: Bristol-Myers Squibb Company; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Lilly USA, LLC Merck; Pfizer 
    Royalties or patent beneficiary: UpToDate

  • Jonathan M. Meyer, MD

    Clinical Professor of Psychiatry 
    University of California, San Diego 
    La Jolla, California

    Disclosures

    Disclosure: Jonathan M. Meyers, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Acadia Pharmaceuticals Inc.; Alkermes, Inc.; Intra-Cellular Therapies, Inc.; Neurocrine 
    Served as a speaker or a member of a speakers bureau for: Acadia Pharmaceuticals Inc.; Alkermes, Inc.; Intra-Cellular Therapies, Inc.; Neurocrine; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.

  • Amanda Simonton, PhD, RN, PMHNP-BC

    Clinical Assistant Professor 
    School of Nursing 
    University of Texas at Austin 
    Austin, Texas

    Disclosures

    Disclosure: Amanda Simonton, PhD, RN, PMHNP-BC, has disclosed no relevant financial relationships. 

  • Trisha Suppes, MD, PhD

    As Seen Above

Editors

  • Clinton W. Wright, PharmD, BCPP

    Medical Education Director
    Medscape, LLC

    Disclosures

    Disclosure: Clinton W. Wright, PharmD, BCPP, has disclosed no relevant financial relationships.

  • Megan Breuer, PhD

    Medical Writer
    Medscape LLC

    Disclosures

    Disclosure: ​Megan Breuer​, PhD, has disclosed ​no relevant financial relationships.​​

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Assess Your Diagnosis and Management of Bipolar Disorder

Authors: Trisha Suppes, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 8/31/2021

Valid for credit through: 8/31/2022

processing....

The goals of continuing medical education (CME) and professional development are to acquire and retain knowledge that will enhance clinical practice and improve patient outcomes. The following self-assessment survey is offered for CME credit and is designed to test your current knowledge and skills related to bipolar disorder and bipolar depression.

  • Print